|
CA3049856A1
|
|
Neutrophil activation regulator
|
|
TW201002341A
|
|
A therapeutic agent for lower urinary tract diseases and an improving agent for lower urinary tract symptoms
|
|
EP2217267A1
|
|
An agent for reducing a side effect of an anticancer drug
|
|
EA014296B1
|
|
Activating agent of stem cells and/or progenitor cells
|
|
TW200801191A
|
|
Activating agent of stem cells and/or progenitor cells
|
|
CN1980690A
|
|
Malignant tumor local infiltration inhibitor containing batroxobin
|
|
CN1972706A
|
|
Malignant tumor-inhibiting preparation comprising des A fibrin
|
|
WO03033471A1
|
|
Novel pyridone derivative and remedial agent for circulatory disease containing the same
|
|
CA2212954A1
|
|
Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases
|
|
JPH09227523A
|
|
Anti-cck active compound derived from serine
|
|
JPH09176162A
|
|
Thiazolidinedione derivative, its production and medicinal composition containing the same
|
|
US5716958A
|
|
Amino acid derivative having anti-CCK activity
|
|
JPH0912475A
|
|
Preventing and therapeutic agent for disorder in ischemia-reperfusion
|
|
JPH08217751A
|
|
Serine, aspartic acid glutamic acid derivative having anti-cck activity
|
|
JPH08176013A
|
|
Therapeutic agent for restenosis and arteriosclerosis
|
|
JPH08176144A
|
|
Serine, aspartic acid and glutamic acid derivative having anti-cck activity
|
|
JPH08119940A
|
|
Serine derivative having anti-cck activity
|
|
JPH02268142A
|
|
Novel compound having muscle relaxing action and production thereof
|
|
JPH01230599A
|
|
Production of compound having antitumor active compound from 'akane'
|
|
JPH0215088A
|
|
Novel method for preparing 7-amino-3-heterocyclic ring-substituted thiomethyl-3-cephem-4-carboxylic acid
|
